Osteoporosis Flashcards

1
Q

Describe the relationship between RANKL, RANK, and OPG in the regulation of osteoclast activation

A
  • activation of osteoclasts requires signaling from osteoblasts
  • RANKL expressed on osteoblasts in response to PTH–>RANKL on blasts activate RANK on clast precursors–>promotes differentiation
  • OPG is a decoy receptor that bind to RANKL and prevents it from activating RANK
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how does estrogen inhibit osteoclast function?

A

increases OPG production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the relationship between circulating calcium levels and the release/production of active vitamin D, parathyroid hormone, and calcitonin

A

Decreased blood calcium–>PTH activated and increases osteoclast activity, increases Ca absorption in kidney, and increases activation of vit D (per kidney), leading to increased intestinal Ca absorption

-calcitonin is a peptide from C cells in thyroid–>when Ca blood levels are high, it decreases plasma calcium by inhibiting osteoclasts–>decreases resorption of bone (salmon calcitonin is used for this effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the regulation of vitamin D production and its actions on circulating calcium levels and bone

A

(PTH helps regulate vit D)
chol is skin +UV–>1st vit D version–>liver adds 25-OH–>kidney adds another OH per PTH–>fully activated vit D–>inc. intestinal absorption of Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the regulation of parathyroid hormone release and its actions on circulating calcium levels and bone

A

high blood Ca levels–>Ca binds to GPCR–>blocks mRNA and translation and inhibition of PTH secretion
-low blood ca–>inhibition removed from GPCR–>PTH released–> increases osteoclast activity, increases Ca absorption in kidney, increased vit D activation for intestinal absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the RFs for osteoporosis?

Understand that osteoporosis is a silent disease that may require prophylactic treatment in high risk individuals

A
  1. decreased estrogen: woman
  2. Ca or Vit D deficiency
  3. chronic glucocorticoid def.
  4. age–> > 50
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Distinguish between medications that are anti-resorptive and anabolic

A

anti-resorptive: HRT, SERMs, salmon calcitonin, bisphosphonates, denosumab

anabolics: teriparatide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which drug is no longer recommended as a first line treatment for management in osteoporosis in post-menopausal women?

A

HRT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

which drug is 1st line treatment of osteoporosis?

A

bisphosphonates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what side effect of bisphosphonates is extremely rare in pts taking it for osteoporosis. The risk is higher in what patient population?

A

osteonecrosis of the jaw

cancer pts taking high dose bisphosphonates for their tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is bisphosphonates major side effect?

A

GI and esophageal irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly